Bank Central Asia BBCA IJ - Buy - Solid YTD Jul-24 results
BBCA’s bank-only Jul-24 earnings of IDR4.9tr (+1% m-m / +17% y-y) brings YTD Jul-24 headline profit to
BBRI posted its Jul-24 bank-only results, which showed decent improvement in the bank’s fundamentals despite muted earnings. We believe that the worst is over for BBRI, and that moving onwards the bank will show operational improvements.
BBRI further slowed micro growth toward ~4.6% y-y, down from ~7% y-y in Jun24. The decline was expected given slower micro deposit growth. We believe this is positive, as it is in line with the bank’s target to improve its asset quality. BBRI’s management has targeted a write-off of approximately IDR40tn for FY24, and in 1H24 it wrote off approximately IDR20tn. Within the total write-off, micro loans is about half. At the moment; BBRI’s management aims to stabilize profits on a y-y basis. So, in the event that core profits and PPOP are strong, the bank would have flexibility to spend more on CoC – in line with our thesis that the bank is moving to improve its asset quality. At the moment, BBRI has not changed its CoC guidance of -3.0% for FY24 despite the fact that YTD Jul24 CoC is about ~3.4%, this means that there is room for improvement in bottom line in 2H24.
We are also seeing improvements in the micro segment, as micro deposit growth also improved to 3% y-y in Jul24 (vs 1.7% in Jun24). This signifies improvement in micro segment purchasing power.
Based on the Indonesia government’s latest 2025 budget, we think there will potentially be less exposure to KURs for BBRI (and hence more commercial-based Kupedes micro loans). This should be positive for the bank, in our view, as Kupedes ROAAs are generally higher than KUR ROAAs. And when combined with likely eased downgrade/write-off risks over the next 12 months, we expect reduced earnings risks for BBRI. In addition, expectations of BI cutting interest rate and issuing fewer SRBI should enable BBRI to register lower funding costs (and hence potentially better NIM trends or at least minimizing NIM risks). On the back of the above-mentioned attributes, we reiterateour Buy rating on the stock. The stock’s relative underperformance over the past three years vs other large-cap bank peers may also represent limited downside risk.
Results summary
Headline July-24-only profit reached IDR3.2tn (-50% m-m; -31% y-y), bringing YTD July-24 profit to IDR31.4tn (+2% y-y), which is largely in line with our FY24 projection (taking into account consolidated numbers).
At the operating level, the bank’s headline July-24 NII of IDR9.3tn showed minor improvement (+0% m-m; +2% y-y). Fortunately, funding costs appear to have stabilized on a m-m basis, with headline May-24 CoF standing at 3.5% (flat m-m; +70bp y-y). Hence, NIM stabilized, as it stood at 6.4% (flat bp m-m; -50bp y-y). Still, in our view, the fact that funding costs have stabilized should pave way for better operating results.
Headline PPOP for July-24 was IDR7.6tn (-20% m-m; +2% y-y), bringing YTD July-24 PPOP to IDR62.5tn (+18% y-y). The decline in monthly PPOP was due to a one-off jump in personnel expenses to reflect adjustment in TER (Tariff Effective Rates) as well as impairment of financial assets. In our opinion, the bank still needs to keep its credit costs (CoC) elevated to beef up its Loan-Loss-Reserve (LLR) to accommodate excess lending in the micro segment done in the past, particularly during 2023 (when micro loan growth was well above micro deposit growth). The increase in CoC is necessary to accommodate some micro loan downgrades, in our view. This resulted in CoC of 3.7% for July-24 (bringing YTD July-24 CoC to 3.4% – well above current management guidance of <3.0% for FY24; this suggests that 2H24 CoC could dip below 3.0%). The bank’s prudent approach has led to LLR of 6.5% (a slight increase from Jun-24, but still down 70bp y-y). Still, among major banks, BBRI has kept the highest LLR – suggesting limited earnings risks going into 2025F, we believe.
In recent months the stock has been under pressure – down 23% YTD. Post results, we see limited earnings risks, and thus we think share price downside should also be limited.
INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).
This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.
The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.
This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.
ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.
RESTRICTIONS ON DISTRIBUTION
By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations.
Rating Remains | Buy |
Target price Remains | IDR 6,000 |
Closing price 28 August 2024 | IDR 5,150 |
Nicholas Santoso (nicholas.santoso@verdhana.id)
Erwin Wijaya (erwin.wijaya@verdhana.id)